Cresilon’s proprietary hemostatic gel technology rapidly controls bleeding when applied to a wound — without the need for manual pressure. (Image: Cresilon)

Rapid and effective control of bleeding can be the difference between life and death in surgery, on the battlefield, and in emergency situations. Excessive bleeding can lead to a rapid drop in blood volume, causing hypovolemic shock, which can be fatal if not addressed promptly. By stopping bleeding quickly, medical personnel can prevent shock and increase the chances of survival.

On this episode of Here's an Idea™, Joe Landolina, CEO and co-founder of Cresilon, discusses a plant-based gel technology that is unlike any other hemostatic agents.

Subscribe  to the Here's an Idea podcast on Apple Podcasts  or Spotify .